Introduction
From time to time, the MHRA may approve batch specific variations to the Marketing Authorisation of COVID-19 vaccines, meaning that some batches may have shelf lives that are different from labelled manufacturer’s expiry date.
Expiry amendments will have been applied to the vaccine cartons by the Specialist Pharmaceutical Logistics (SPL) providers before receipt by vaccination sites.
Following the issue of an expiry extension by a manufacturer, the National Vaccination Programme in England will decide if and when the extension will be applied to existing stocks. Only the extensions approved for implementation by the National Vaccination Programme will appear on this web page.
Update history
- Comirnaty BA.4-5 information removed as vaccine no longer in use
- Minor changes to improve clarity of text and removal of reference to handling frozen vaccine.
- Information on supply of Comirnaty Original/Omicron BA.4-5 without a shelf life communication added. Information relating to Novavax and Comirnaty 10 removed. Page format updated.
- Nuvaxovid and Comirnaty Original/Omicron BA.4-5 expiry extensions added
- Spikevax Original extension now no longer in effect because all affected batches have now expired.
- Published